Personnel Moves Archives - Page 4 of 42

Augmedics CEO takes over corner office at CVRx

Incoming CVRx CEO Kevin Hykes. [Image courtesy of Revival Healthcare Capital]CVRx (Nasdaq:CVRX) announced today that it appointed Kevin Hykes as its new president and CEO, effective Feb. 12.

Hykes already has familiarity with the Minneapolis-based neurostimulation technology developer, having joined its board in December 2022. He will continue to serve on the board, with CEO Nadim Yared set to retire from the company and resign his board seat.

Yared agreed to consult with the company to ensure a seamless transition as Hykes takes over the corner office.

“I am excited to be stepping into the role of CEO after over a year as an independent board member. I have spent the last 32 years commercializing disruptive medical devices like Barostim with the goal of bringing them to standard of care and making a difference in patient’s lives,” said Hykes. “The team has done a tremendous job demonstrating a strong clinical benefit and driving commercial adoption of Baro…

Former Insulet exec joins Imperative Care as COO amid number of leadership moves

Imperative Care COO Chuck Alpuche [Image from Alpuche’s LinkedIn page]Imperative Care announced today that it appointed Chuck Alpuche as its new COO along with a slew of leadership changes.

The stroke care company named Peter Griffin as SVP of operations, Scott Elliott as chief legal officer and Daniel Davis as chief strategy officer, too.

Fred Khosravi, Imperative Care CEO and chair, said the moves come amid an “inflection point of operational scale and excellence.” In August, Imperative Care implemented a new organizational structure designed to accelerate growth.

The company now stands as the parent company of four businesses. These businesses all share a common goal of bringing care to those affected by stroke and other ischemic diseases.

“Chuck and Peter together have made an indelible impact in elevating the treatment of diabetes, and they will turn their attention to doing the same for stroke and thrombectomy care,” Kho…

Longtime Inspire Medical board member Dr. Jerry Griffin to retire

Inspire Medical Systems (NYSE:INSP) announced today that Dr. Jerry C. Griffin intends to retire from its board of directors.

Griffin plans to retire at the conclusion of the company’s annual meeting of stockholders on May 2, 2024.

The longtime director joined the Inspire board in 2008 as one of the original board members. He joined before the company’s initial Series A financing round.

Most recently, Griffin served on the board’s Nominating and Corporate Governance Committee. He departs the board shortly after Inspire brought on another experienced member in Dr. Myriam J. Curet. Curet, whose appointment went into effect on Dec. 21, currently serves as EVP and chief medical officer at surgical robotics pioneer Intuitive Surgical.

“After sixteen years of service, we announce the retirement of Dr. Griffin from our board of directors. His contributions to our board and organization are innumerable and we are grateful for the dedicati…

Lantheus announces a new CEO

Lantheus Holdings’ incoming CEO Brian Markison [Image courtesy of Lantheus]

Radiopharmaceutical-focused Lantheus Holdings (NASDAQ: LNTH) announced today that current board chair and industry veteran Brian Markison will become the company’s CEO, effective March 1.

Markison succeeds Mary Anne Heino, who is retiring from Lantheus’ corner office after leading the company for nine years. Heino will serve as board chair after March 1. Board member Julie McHugh will become lead independent director effective immediately.

“Brian is perfectly suited to lead Lantheus as the company enters its next growth phase. He has held the chair role for more than 10 years and in that role has overseen company strategy. He knows our exceptional executive team well and brings decades of leadership experience as the CEO of public companies with development, commercialization and manufacturing expertise, includin…

Former Boston Scientific exec joins pulsed field ablation company Mirai Medical’s board

New Mirai Medical non-executive board director David Pierce. [Image from Boston Scientific]Mirai Medical announced today that it appointed former Boston Scientific (NYSE: BSX) + executive David A. Pierce as a non-executive board director.

Pierce spent 31 years at Boston Scientific, gaining valuable experience in product commercialization, market access and clinical change management. Much of his work came in the gastrointestinal endoscopy space, providing expertise he can now bring to Mirai Medical. Pierce retired from his post as EVP and president of medsurg and endoscopy at Boston Scientific in July 2022.

“We are thrilled to welcome David to our board,” Mirai Medical CEO Declan Soden said in a news release. “His extensive experience at Boston Scientific, coupled with his deep knowledge of the industry, will undoubtedly play a pivotal role in guiding Mirai Medical’s strategic direction. As leaders in pu…

Getinge appoints Agneta Palmér as CFO

Agneta Palmér [Image courtesy of Getinge]Getinge announced today that it appointed Agneta Palmér as chief financial officer.

Palmér will succeed Lars Sandström, who is leaving Getinge for a new opportunity outside of the company. Palmér most recently was the EVP of operations services at Getinge and has been with the company since 2018.

”I am very pleased that Agneta is taking over as CFO. She has extensive experience from finance in global operations and has in-depth knowledge of Getinge’s business. In addition, in her previous role, she has been involved in establishing our current finance organization, which she will now continue to develop,” Getinge President and CEO Mattias Perjos said in a news release.

Before becoming EVP of operations services, Palmér was VP of corporate control at Getinge. She held similar roles at AB Volvo.

Her appointment takes effect at the end of March when Sandström steps down.

”Lars has contributed …

Insulet has new directors as former CEO is set to retire from board

Shacey Petrovic

Insulet (Nasdaq: PODD) + announced today that it named a duo of new board directors with high-profile figures set to retire.

Acton, Massachusetts-based Insulet appointed Flavia Pease and Timothy Stonesifer to its board. Former CEO Shacey Petrovic, along with Corinne Nevinny, intend to retire from the board in May.

Petrovic spent more than seven years as CEO at the automated insulin delivery technology developer. She stepped down from the corner office in May 2022 and remained on the board as Jim Hollingshead took over as CEO. Petrovic spent nearly six years on the board at Insulet, while Nevinny offered five years of service to the board.

Get the full story at our sister site, Drug Delivery Business News.

Cardiac Dimensions has a new chief medical officer

Satya Shreenivas. [Image courtesy of Cardiac Dimensions]Cardiac Dimensions announced today that it appointed Dr. Satya Shreenivas as its new chief medical officer (CMO).

Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatments for heart failure with functional mitral regurgitation (FMR). That includes the Carillon Mitral Contour System, for which the company has the ongoing EMPOWER trial. Its new CMO served as an advisor on that trial.

“I’ve seen the compelling clinical evidence on Carillon therapy from Europe and look forward to helping the team expand the supportive body of evidence for this intriguing technology with the U.S. pivotal EMPOWER trial,” said Shreenivas. “I have always been energized by my work with emerging technologies that fill an unmet clinical need and am excited by the opportunity this therapy presents to enhance the lives of heart failure patients in a way that isn’t possible today.”

More about the new CMO at C…

3M picks former NuVasive CEO as president of Medical Solutions

New 3M Medical Solutions President J. Christopher Barry. [Image from NuVasive]3M (NYSE: MMM) + announced that it named Chris Barry EVP and group president of its Medical Solutions Division.

Medical Solutions exists within the 3M Health Care business group. 3M expects to spin off its Health Care business in the first half of this year, after which point it will operate under the name “Solventum.”

Barry, the former CEO of NuVasive, is the latest in a string of high-profile appointments at the 3M unit. Bryan Hanson announced his departure from the corner office at Zimmer Biomet to take over the company in August. The company also landed former Insulet CFO Wayde McMillan as he takes over the same post.

The appointment of Barry goes into effect on March 1. 3M expects him to help drive profitable growth for the unit, which provides advanced wound care solutions.

Barry brings more than two decades of ex…

Medtronic brings back former VP as GM of Aortic unit

Simona Zannetti, GM of the Medtronic Aortic business unit. [Image from Simona Zannetti on LinkedIn]Medtronic (NYSE: MDT) + announced that it named Dr. Simona Zannetti as the GM of its Aortic business unit.

Zannetti previously spent 21 years at the medtech giant. She spent the last 16 months as SVP of clinical research at Penumbra, joining the interventional device maker in September 2022.

In a LinkedIn post today, Nina Goodheart, SVP and president, Structural Heart & Aortic at Medtronic, shared the news of Zannetti’s return.

“She is a familiar face to many of us and we’re so glad to have her back,” Goodheart wrote.

Among several roles at Medtronic over more than two decades, Zannetti most recently served as VP of clinical research and medical science for peripheral vascular health. She also had the post of VP of clinical research and the Office of Medical Affairs, Aortic, Peripheral and…

Orthofix has a new CFO as Massimo Caliafiore takes over as CEO

LimaCorporate CEO Massimo Calafiore

Orthofix Medical (Nasadaq: OFIX) + announced that it appointed a new CFO as its newly appointed CEO takes over the corner office.

The large orthopedic device maker appointed Julie Andrews as CFO as Massimo Calafiore assumes his position as CEO. Orthofix named Calafiore as its next CEO in November. However, the company had to wait until Enovis completed its acquisition of LimaCorporate for the appointment to go into effect. Calafiore served as Lima’s CEO until Enovis completed its acquisition last week.

Orthofix’s executive appointments come as part of a major shuffle at the top following the termination of three high-ranking executives. After the company began 2023 with a massive merger with SeaSpine, in September, it terminated a trio of executives with cause. The company cut ties with CEO Keith Valentine, CFO John Bostjancic and chief legal officer Patrick Keran followi…

SimBioSys wins FDA nod for TumorSight precision medicine platform

SimBioSys announced that it received FDA 510(k) clearance for its TumorSight cloud-based digital precision medicine platform.

FDA clearance came just days after the company inked a partnership with Mayo Clinic to develop precision medicine solutions.

The TumorSight platform takes a patient’s standard-of-care imaging to build a custom 3D model of their tumor. The tool provides 3D spatial visualizations of breast cancer to support more effective planning and consultations. SimBioSys said it gives clinicians and patients a more comprehensive understanding of their cancer and the potential options available.

Additionally, the TumorSight application provides insights like tumor volume, tumor-to-breast volume and tumor distance to key anatomical structures. It quantifies key metrics required in treatment planning.

SimBioSys also plans to expand the TumorSight platform and incorporate a suite of innovative tools. Those tools could extend to surgical plan…